Sergey Badalyan, Medical Oncology Resident at Yeolyan Hematology and Oncology Center, Publishing Editor at OncoDaily, shared a post on LinkedIn:
“ACT for Children: How Armenia is Changing Pediatric Oncology.
In my latest OncoDaily conversation, I spoke with Jennifer Lowe (Chief Research Officer at Resonance) about the ACT 4 Children initiative, which is a hospital-based global program designed to expand access to high-quality pediatric cancer care.
What makes this particularly important for us:
Armenia is the first country to implement ACT for Children.
- The initiative brings together strategic collaborations with leading pharmaceutical companies.
- It operates through multi-country partnerships, strengthening institutional capacity rather than isolated projects.
- A new quality improvement framework is being introduced to standardize and elevate pediatric oncology care delivery.
For Armenia, this is more than participation in a global program, it’s about building structured, measurable, and sustainable improvements in childhood cancer care.
If you’re working in oncology, health systems strengthening, or global health partnerships, this model is worth examining closely.”
Other articles featuring ACT for Children on OncoDaily.
